Detalhe da pesquisa
1.
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial.
Clin Cancer Res
; 29(14): 2602-2611, 2023 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36799931